<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ex vivo susceptibility | Nick Brazeau</title><link>https://nicholasbrazeau.com/tags/ex-vivo-susceptibility/</link><atom:link href="https://nicholasbrazeau.com/tags/ex-vivo-susceptibility/index.xml" rel="self" type="application/rss+xml"/><description>ex vivo susceptibility</description><generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>Â© 2022 Nicholas Brazeau</copyright><lastBuildDate>Thu, 01 Jun 2017 00:00:00 +0000</lastBuildDate><image><url>https://nicholasbrazeau.com/img/headers/tree.jpg</url><title>ex vivo susceptibility</title><link>https://nicholasbrazeau.com/tags/ex-vivo-susceptibility/</link></image><item><title>Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia</title><link>https://nicholasbrazeau.com/publication/parobek-partner-drug-2017/</link><pubDate>Thu, 01 Jun 2017 00:00:00 +0000</pubDate><guid>https://nicholasbrazeau.com/publication/parobek-partner-drug-2017/</guid><description/></item></channel></rss>